Clinical response and remission in patients with baseline C reactive protein >4 mg/l: groups I and II combined
| Day 28 results | Placebo (n = 20) | Fontolizumab | |
|---|---|---|---|
| 4 mg/kg (n = 25) (p value*) | 10 mg/kg (n = 24) (p value*) | ||
| *Compared with placebo group. | |||
| CDAI, Crohn’s disease activity index. | |||
| Clinical response (CDAI drop ⩾100 points) | 4 (20%) | 11 (44%) (0.12) | 11 (46%) (0.11) |
| Clinical remission (CDAI ⩽150) | 0 | 10 (40%) (<0.01) | 4 (17%) (0.11) |